Arcutis Biotherapeutics, Inc. ARQT Business Segments — Selling, general, and administrative
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s business segments — selling, general, and administrative.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s business segments — selling, general, and administrative?
- Arcutis Biotherapeutics, Inc. (ARQT) reported business segments — selling, general, and administrative of $73.95M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s business segments — selling, general, and administrative changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s business segments — selling, general, and administrative increased by 15.8% year-over-year, from $63.88M to $73.95M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s business segments — selling, general, and administrative?
- Over 3 years (2022 to 2025), Arcutis Biotherapeutics, Inc.'s business segments — selling, general, and administrative has grown at a 31.0% compound annual growth rate (CAGR), from $121.76M to $274.03M.
- What does business segments — selling, general, and administrative mean?
- Encompasses the overhead costs associated with the segment's commercial operations, including marketing, sales force support, and general administrative functions. It represents the operational investment required to scale market presence and support product commercialization.